These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11562576)

  • 1. Molecular mechanisms of cellular interactions in peripheral nerve regeneration.
    Küry P; Stoll G; Müller HW
    Curr Opin Neurol; 2001 Oct; 14(5):635-9. PubMed ID: 11562576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrinsic cellular and molecular mediators of peripheral axonal regeneration.
    Bosse F
    Cell Tissue Res; 2012 Jul; 349(1):5-14. PubMed ID: 22476657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between neuronal survival and regeneration.
    Goldberg JL; Barres BA
    Annu Rev Neurosci; 2000; 23():579-612. PubMed ID: 10845076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is Wallerian degeneration in the CNS so slow?
    Vargas ME; Barres BA
    Annu Rev Neurosci; 2007; 30():153-79. PubMed ID: 17506644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction.
    Dubový P
    Ann Anat; 2011 Jul; 193(4):267-75. PubMed ID: 21458249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury.
    Chen P; Piao X; Bonaldo P
    Acta Neuropathol; 2015 Nov; 130(5):605-18. PubMed ID: 26419777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular inflammatory mediators in peripheral nerve degeneration and regeneration.
    Cámara-Lemarroy CR; Guzmán-de la Garza FJ; Fernández-Garza NE
    Neuroimmunomodulation; 2010; 17(5):314-24. PubMed ID: 20407283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-C expression during wallerian degeneration in C57BL/Wlds mice: possible implications for axonal regeneration.
    Fruttiger M; Schachner M; Martini R
    J Neurocytol; 1995 Jan; 24(1):1-14. PubMed ID: 7539482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide in damage, disease and repair of the peripheral nervous system.
    Zochodne DW; Levy D
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):255-67. PubMed ID: 16191393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model.
    George R; Griffin JW
    Exp Neurol; 1994 Oct; 129(2):225-36. PubMed ID: 7957737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 3: Histology of the peripheral nerve and changes occurring during nerve regeneration.
    Geuna S; Raimondo S; Ronchi G; Di Scipio F; Tos P; Czaja K; Fornaro M
    Int Rev Neurobiol; 2009; 87():27-46. PubMed ID: 19682632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Association of Neuroscience review: axonal regeneration in the peripheral and central nervous systems--current issues and advances.
    Fenrich K; Gordon T
    Can J Neurol Sci; 2004 May; 31(2):142-56. PubMed ID: 15198438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve physiology: mechanisms of injury and recovery.
    Menorca RM; Fussell TS; Elfar JC
    Hand Clin; 2013 Aug; 29(3):317-30. PubMed ID: 23895713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 24: Electrical stimulation for improving nerve regeneration: where do we stand?
    Gordon T; Sulaiman OA; Ladak A
    Int Rev Neurobiol; 2009; 87():433-44. PubMed ID: 19682653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inflammation and cytokines in peripheral nerve regeneration.
    Dubový P; Jančálek R; Kubek T
    Int Rev Neurobiol; 2013; 108():173-206. PubMed ID: 24083435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve.
    Lawson LJ; Frost L; Risbridger J; Fearn S; Perry VH
    J Neurocytol; 1994 Dec; 23(12):729-44. PubMed ID: 7897440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative changes of schwann and mast cells in the process of peripheral nerve regeneration.
    Giorgadze T; Rukhadze R; Giorgadze S; Gujabidze N; Tevzadze N
    Georgian Med News; 2010 Nov; (188):84-8. PubMed ID: 21178210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schwann cell proliferation during postnatal development, Wallerian degeneration and axon regeneration in trembler dysmyelinating mutant.
    Koenig H; Do Thi A; Ferzaz B; Ressouches A
    Adv Exp Med Biol; 1991; 296():227-38. PubMed ID: 1781329
    [No Abstract]   [Full Text] [Related]  

  • 19. Difference in the morphology of Wallerian degeneration in the central nervous system (CNS) and peripheral nervous system (PNS) and its effect on regeneration.
    Wisniewski HM
    Birth Defects Orig Artic Ser; 1983; 19(4):389-95. PubMed ID: 6871406
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth promoting and inhibitory effects of glial cells in the mammalian nervous system.
    Hirsch S; Bähr M
    Adv Exp Med Biol; 1999; 468():199-205. PubMed ID: 10635030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.